Form 483

Sincerus Florida, LLC dba SKNV Form 483, 2024-05-23

FDA issued a Form 483 to Sincerus Florida, LLC dba SKNV on 2024-05-23 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Sincerus Florida, LLC dba SKNV · Pompano Beach, United States · Issued May 23, 2024

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 May 2024
FDCA 503B(a)(10)(B)

Drug product container, fails to include

Cited by Jared P Stevens

23 May 2024
FDCA 503B(b)(2)(A)

Outsourcing facility, compounded drug report follow up

Cited by Jared P Stevens

Inspected site

SFSincerus Florida, LLC dba SKNVPompano Beach, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 503B(a)(10)(B)Cited across public-safe Form 483 observations1x
FDCA 503B(b)(2)(A)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere